Spyre Therapeutics Inc (SYRE)

Operating Income Growth

0.71%

Quarterly · Period ending:

SYRE logo

SYRE Operating Income Growth

Year-over-year change vs the same period a year earlier

Latest reported0.71%
SYRE Quarterly Operating Income YoY % (-188.10% → 0.71%)
High-resolution chart · PNG

SYRE operating income growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Operating Income Growth — Quarterly
Period endingOperating Income Growth
0.7059%
14.7964%
6.6625%
-2.7008%
5.0105%
-12.1258%
-33.4081%
-202.0778%
72.2775%
-154.0359%
-139.6096%
2.2287%
-610.1904%
23.0555%
6.2616%
7.579%
-234.4221%
-34.2248%
10.2476%
-11.9737%
68.9007%
4.274%
-3.9573%
18.1658%
-15.777%
-7.7306%
-43.1493%
-80.887%
-92.575%
-114.154%
-130.984%
-53.0758%
-43.8988%
-30.2322%
-19.5382%
-26.9322%
-22.293%
-38.6249%
-38.679%
-84.4015%
-283.7291%
-84.9737%
-25.6523%
-8.8217%
17.0336%
-188.098%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.